Boiron : Simplified takeover bid at € 50 with an exceptional dividend set at € 10.36/share: a low price in our view
>Acquisition by the family at € 50, with EW Healthcare Partners - After the suspension of trading yesterday, Boiron announced a simplified takeover bid with the intention of delisting the stock from the market, based on an offer price of € 50, corresponding to the last closing price + an exceptional dividend of € 10.36 per share.The family, via Boiron Développement and EW Healthcare Partners (ex. Essex Woodlands, a private equity fund based in the US) and possibl...Boiron manufactures and markets homeopathic medicines. Homeopathic medicines are prepared from vegetable, animal, mineral, or chemical substances, which are diluted. Co. sells three types of products in 59 countries: Non-proprietary homeopathic medicines, OTC family medication specialties, and Other products. There are two large families of homeopathic medicines: Those associated with precise therapeutic indications and dosage, and those that do not mention a therapeutic indication or dosage. Co. supports homeopathy education and training organizations for healthcare professionals. Some of Co.'s brand names include Oscillococcinum®, Stodal®, S?datif PC®, and Coryzalia.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.